Navigation Links
Visceral Leishmaniasis: Successful Vaccine Trial In Dogs

als are thus a reservoir for these parasites, which continuously feed the mammal-sand fly-human cycle. In this context, development of a canine vaccine would help reduce the portion of the animal population infected. The risks of transmission of the disease to humans would in this way be indirectly reduced.

Up to now, several dog vaccines, mostly developed from whole dried parasites, have proved not to be really effective. A team from the IRD Montpellier research centre, working with the Rocher veterinary clinic (La Garde, Var, France) and the biopharmaceutical firm Bio Véto Test (La Seyne-Sur-Mer, Var), have recently produced and tested a new type of treatment, composed solely of antigen proteins excreted by the parasite (1). The first trials indicate that this would completely and lastingly protect dogs against the disease.

Twelve out of 18 dogs included in the study were treated with increasing doses of protein antigens excreted by the parasite (that is 50, 100, 200 micrograms) made up to a formula with an adjuvant. The other six received no treatment. Two injections at an interval of three weeks resulted in infection of all the animals with L. infantum. They were followed up for two years in order to monitor the progress of the disease. The mixture of parasite proteins proved to be especially effective, as 100% protection was obtained for the doses of 100 micrograms (six immunized dogs out of six) and 200 micrograms (three out of three).

The researchers also focused on the changes to the immune system brought on by the vaccination. Laboratory experiments showed that the effectiveness of the vaccine stems from the activation of certain cells of the immune system, the T lymphocytes of type Th1. These induce the infected macrophages to produce nitric oxide, highly toxic for cells. This process, which did not occur in the untreated dogs, thus enables macrophages to get rid of the parasites that are infecting them. The animal thus acquires lon
'"/>

Source:Institut de Recherche Pour le D茅veloppement


Page: 1 2 3 4

Related biology news :

1. Successful Test Of Single Molecule Switch Opens The Door To Biomolecular Electronics
2. Penn Surgeons Use Completely Robotic Surgery to Successfully Treat Prostate Cancer
3. Successful cell engineering may lead to mad cow prevention, say researchers
4. Successful transplantation from pig embryos to mice
5. Successful lung cancer surgery not enough to break nicotine dependence in many smokers
6. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
7. Live Recombinant Adenovirus Vaccine Technique Explored
8. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
9. NIAID Initiates Trial of Experimental Avian Flu Vaccine
10. Study Models Impact Of Anthrax Vaccine
11. New Insights Into HIV Immunity Suggest Alternative Approach to Vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Visceral Leishmaniasis Successful Vaccine Trial Dogs

(Date:2/5/2015)...  It is gratifying to see that the Obama ... science as a means to better understand human biology, ... was honored to participate in today,s White House event ... Since the 1980s my teams have been ... sequenced genome of a free living organism, the first ...
(Date:1/22/2015)... FindBiometrics, the leading source of biometrics industry news, interviews and ... "When we launched FindBiometrics 12 years ago the ... founder and CEO of FindBiometrics. "Now it,s maturing very quickly. ... players on a very broad scale.  We are known for ...
(Date:1/22/2015)...  A man-made form of insulin delivered by nasal spray ... adults with mild cognitive impairment and Alzheimer,s disease dementia, ... Wake Forest Baptist Medical Center. The study,s ... impairment (MCI) or mild to moderate Alzheimer,s dementia (AD). ...
Breaking Biology News(10 mins):J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... researchers from across North America have been awarded ... at Stanford University,s Woods Institute for the Environment, ... to help academic scientists make their knowledge accessible ... selects up to 20 mid-career academic environmental researchers ...
... is free of charge for all holders of a ... have access to the onsite press facilities, including a ... staff will also be able to assist you in ... You can register for free online at: http://www.eular.org/congress_press_registration.cfm ...
... University in St. Louis scientists are imitating nature as they ... orthopedic surgery: reattaching tendon to bone. Their goal is ... rotator cuff is the group of four tendons and muscles ... tendons tear or detach from the bone. Commonly thought ...
Cached Biology News:20 researchers selected as 2011 Leopold Leadership Fellows 220 researchers selected as 2011 Leopold Leadership Fellows 320 researchers selected as 2011 Leopold Leadership Fellows 4Biomimetic patch to be tested on tricky tendon-to-bone repairs 2Biomimetic patch to be tested on tricky tendon-to-bone repairs 3Biomimetic patch to be tested on tricky tendon-to-bone repairs 4
(Date:3/5/2015)... 5, 2015  Twelve patients today are preparing to ... transplant at California Pacific Medical Center (CPMC), a Sutter ... procedure will be the largest single-center kidney paired donation ... conducted in the 44-year history of the CPMC Transplant ... with an altruistic donor who did not have a ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Bi-Biomics ... Histology’s paraffin and stain additive. The improvement in ... the binary features present in all daughter cells. ... protocol, chromatin packaging was analyzed at 1000-1600x using ... that chromatin patterning in all daughter cells displayed ...
(Date:3/5/2015)... 2015  In response to the incorrect assertions by ... on February 12, 2015. Impeto Medical SAS ... health and their SUDOSCAN® devices have been proven to ... prefers to have the courts decide this dispute rather ... 40 articles written by Key Opinion Leaders, published by ...
(Date:3/4/2015)... 2015 In an article published and posted ... Health Security review the clinical aspects of diseases caused ... bioweapons. The article, "Clinical Management of Potential Bioterrorism-Related Conditions," ... of the New England Journal of Medicine . ... , and Tom Inglesby—review the clinical management of conditions ...
Breaking Biology Technology:Altruistic donor starts large West Coast single-center kidney paired donation at CPMC 2Altruistic donor starts large West Coast single-center kidney paired donation at CPMC 3Altruistic donor starts large West Coast single-center kidney paired donation at CPMC 4Impeto Medical Responds to Published Allegations by LD Technology LLC ("LD") 2Latest Clinical Information On Bioterrorism Threats 2
... Therapeutics (Euronext: AMT), a leader in the field ... Board has decided to,propose Dr. George Morstyn to ... General Meeting of shareholders on April 16, 2008. ... Senior Vice President of Development at,Amgen, was a ...
... Fla., April 1, 2008 MiMedx Group, Inc.,(OTC ... (OTC Bulletin,Board: AYXC), today reported that the contemplated ... Florida and related name change, to,MiMedx Group, Inc., ... 2008. As a result of the reverse split ...
... VWR International,LLC, a leading global laboratory supply company, ... a UK scientific laboratory,supply distributor., Jencons is ... equipment,and consumables with 110 employees. Based in the ... and North America. The Company has annual,revenues of ...
Cached Biology Technology:Amsterdam Molecular Therapeutics to Appoint George Morstyn to Supervisory Board 2Amsterdam Molecular Therapeutics to Appoint George Morstyn to Supervisory Board 3MiMedx Group Announces Post-split Name Change 2MiMedx Group Announces Post-split Name Change 3VWR International, LLC Acquires Jencons (Scientific) Ltd, UK 2
Mouse polyclonal antibody to PRDM2 - PR domain containing 2, with ZNF domain...
Hepatocyte Differentiation Environment...
Mouse monoclonal [M2II-12] to MRP2 ( Abpromise for all tested applications). entrezGeneID: 1244 SwissProtID: Q92887...
...
Biology Products: